Related Experiment Videos
Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): an immunophenotypic study
1Institute of Pathology, University of Graz Medical School, Austria.
Histopathology
|May 1, 1994
Summary
Proliferation centres in B-cell chronic lymphocytic leukemia (B-CLL) contain follicular dendritic cells and exhibit higher cell proliferation than surrounding tissue. These centres show increased T-cells and decreased bcl-2 protein expression.
Area of Science:
- Hematology
- Oncology
- Immunohistochemistry
Background:
- Proliferation centres, or pseudofollicles, are characteristic of B-cell chronic lymphocytic leukemia (B-CLL), found in ~90% of cases.
- These structures differ from true B-cell follicles, with prior uncertainty regarding follicular dendritic cell presence.
Purpose of the Study:
- To investigate the immunohistochemical characteristics of proliferation centres in B-CLL.
- To compare proliferation centres with surrounding lymphocytic infiltrate and entrapped reactive B-cell follicles.
Main Methods:
- Immunohistochemical analysis of 30 B-CLL lymph node specimens.
- Comparison of proliferation centres, surrounding infiltrate, and reactive follicles for follicular dendritic cells, IgM, complement, proliferation fraction, T-cells, and bcl-2 expression.
Main Results:
- Most proliferation centres exhibited a delicate follicular dendritic cell network with IgM and complement, higher proliferation rates, more T-cells, and decreased bcl-2 expression compared to the surrounding infiltrate.
- Entrapped reactive B-cell follicles showed denser follicular dendritic cell networks, stronger IgM/complement expression, very high proliferation rates, abundant T-cells, and minimal bcl-2 expression.
Conclusions:
- Proliferation centres in B-CLL possess distinct immunohistochemical features, including the presence of follicular dendritic cells and elevated T-cell infiltration.
- These findings contribute to understanding the microenvironment and cellular dynamics within B-CLL, differentiating them from reactive B-cell follicles.